跳至主要内容
临床试验/NCT00934466
NCT00934466已完成1 期

A Randomized Clinical Trial to Assess the Effects of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability in Healthy Subjects

Merck Sharp & Dohme LLC0 个研究点目标入组 15 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
15
主要终点
Increase in Motor Evoked Potential (MEP) after dosing with dextromethorphan compared to placebo

研究概览

简要总结

This study will assess transcranial magnetic stimulation (TMS) as a biomarker and characterize TMS readouts of the activity of MK2637 and dextromethorphan. Resting quantitative electroencephalography(qEEG) readouts are also characterized with MK2637 and dextromethorphan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Subject is right-handed
  • Subject is in good health
  • Subject is a nonsmoker

排除标准

  • Subject works a night shift
  • Subject has a history of any illness that might make participation in the study unsafe or confound the study results
  • Subject has a history of head injury

研究组 & 干预措施

1

Experimental

MK2637 120 mg

干预措施: MK2637 (Drug)

结局指标

主要结局

Increase in Motor Evoked Potential (MEP) after dosing with dextromethorphan compared to placebo

时间窗: 5 Hours after initial dosing

Increase in amplitude in the gamma frequency band (24-60 Hz) of resting qEEG after dosing with dextromethorphan compared to placebo

时间窗: 4 Hours after initial dosing

次要结局

  • Change in Motor Evoked Potential (MEP) after dosing with MK2637 as compared to placebo(5 hours after initial dosing)
  • Increase in amplitude in the theta frequency band (4-8 Hz) of resting qEEG after dosing with MK2637 compared to placebo(6.5 hours after initial dosing)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验